Clear-aligner shipments rose 6.6% to 690,635 cases at Align Technology.

Align Technology reported Q3 2026 revenues of $1.015 billion, up 1.9% YoY. Clear Aligner revenues rose 4.2% YoY to $839.3 million, with shipments up 6.6% to 690,635 cases. Imaging Systems and CAD/CAM Services revenues fell 7.6% YoY. Gross margin was 68.7% (70.4% non-GAAP), and operating margin improved to 16.7% (24.4% non-GAAP). The company repurchased 627.3K shares and expects Q4 revenues between $1.020B and $1.000B.

Original reporting
Published Oct 28, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ALGN
Bullish
high confidence
Mentioned
$ALGN
Relevance
8/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ALGNBullishHigh
01

Why it matters

The earnings beat and optimistic outlook could drive short‑term buying interest and support the stock price.

02

Market read

First‑time disclosure of Q3 results and FY2027 guidance makes this a material earnings event for traders.

03

What to watch

Potential supply chain constraints for 3D‑printing materials and competitive pressure from emerging aligner makers.

Relevance 8/10Novelty 8/10Timing: post-market release

Background

Align Technology reported its Q3 FY2026 earnings, highlighting modest revenue growth, improved margins, and a continued share repurchase program.

Company-level read

Ticker impact

$ALGNBullishHigh confidence
Context

Q3 FY2026 results show 1.9% YoY revenue growth, margin expansion and a $627k share repurchase, plus upbeat FY2027 outlook.

Expected impact

likely upward pressure as investors price in stronger margins and buyback activity

Evidence & confidence

Revenue and margin beat expectations, share repurchase signals confidence, and guidance remains optimistic, all fresh data.

Market effects

Dental and orthodontic equipment sector may see modest uplift from Align's growth and margin expansion.

U.S. healthcare equipment market could benefit from Align's strong performance.

Align's international growth hints at broader demand for clear aligner solutions worldwide.

Counterpoint

Margin expansion may be temporary if discretionary spending softens further; growth could stall.

Key entities

  • Joe Hogan

    President and CEO of Align Technology, provided commentary on results.

  • John Morici

    CFO and EVP Global Finance, discussed financial performance and outlook.

Related articles

$ALGNMed

Align Technology Inc (ALGN) Q3 2026 Earnings Call Highlights: Record Doctor Submitters

Align Technology (ALGN) reported Q3 2026 earnings with record 91,000 doctor submitters (+3% YoY) and Clear Aligner shipments up 6.6% to 691,000. Non-GAAP operating margin was 24.4%, exceeding outlook. Revenue growth slowed to 1.9% YoY, with Systems & Services revenue down 7.6%. ASP declined 2.3% YoY. Q4 guidance was reduced due to consumer challenges and lower ASP assumptions. The company highlighted innovation in sports mouthguards and margin improvement plans for 2027.

$ALGNMedAI 8/10

ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls

Align Technology (ALGN) reported Q3 2026 earnings of $2.80 per share, up 7.3% YoY, and revenues of $1.01B, up 1.9% YoY. Clear Aligner shipments increased 6.6% YoY. ALGN shares fell 0.7% post-earnings. The company lowered its 2026 revenue outlook, citing softer expectations for Systems and Services business. Q4 revenue guidance is $1.00-$1.02B, below consensus of $1.05B.